NCI Specialized Program Of Research Excellence
Prostate Cancer SPORE
Overview
The UCSF Prostate Cancer SPORE (Specialized Program Of Research Excellence) is sponsored by the National Cancer Institute, with the goal of improving diagnosis, prognostication, and therapy of prostate cancer.
The SPORE includes basic researchers, physicians, population scientists, and patient advocates in the research process, concentrating in the areas of epidemiology, cancer genetics, cancer biology, and molecular therapeutics. Researchers are supported by six core resources, and overall directions are selected by a steering committee. A clinical advisory committee helps maintain a translational focus.
The SPORE focuses primarily on the development of new therapeutic approaches to prostate cancer treatment and prevention using molecular insights gained from the wealth of basic cancer research ongoing at the University of California, San Francisco. The SPORE is organized into projects, a developmental research program, and core areas.
Principal Investigators
Marc A. Shuman, MD | Peter R. Carroll, MD | Eric Small, MD
Core Areas
Administrative | Tissue | Animal | Advocacy
Main Research Projects
Genomics of Prostate Cancer More >
Antibody Gene Diversity Libraries and Phage Display to Generate Recombinant Human Antibodies for Prostate Cancer Therapy More >
Anti-CTLA-4-Based Immunologic Therapy for Prostate Cancer More >
Alternatives to Antiandrogens More >
Developmental Research Program
